Company record
Nephron SC Inc.
1 FDA warning letter since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about Nephron SC Inc..
Warning letters
-
DrugsNephron SC Inc.
Nephron SC's sterile drug manufacturing had unresolved cross-contamination and microbial contamination, making its drugs adulterated.
High risk
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Apr 22 | Class II | Nephron SC, LLC Drug |
Albuterol Sulfate Inhalation Solution, 0.5%, 25 mg/5 mL (5 mg/mL*), 30x5 mL Sterile Unit-Dose Vials, Rx only, nephron 503B Outsourcing facility, 4600 12th Street Extension, West Columbia, SC 29172, NDC 69374-330-05. Labelling: Illegible label |